Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $66.7 million.

  • Angiodynamics' Goodwill & Intangibles fell 872.38% to $66.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $66.7 million, marking a year-over-year decrease of 872.38%. This contributed to the annual value of $69.1 million for FY2025, which is 1068.32% down from last year.
  • Angiodynamics' Goodwill & Intangibles amounted to $66.7 million in Q4 2025, which was down 872.38% from $68.4 million recorded in Q3 2025.
  • Angiodynamics' 5-year Goodwill & Intangibles high stood at $387.3 million for Q1 2021, and its period low was $66.7 million during Q4 2025.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $268.0 million (2023), whereas its average is $230.8 million.
  • In the last 5 years, Angiodynamics' Goodwill & Intangibles tumbled by 455.18% in 2022 and then tumbled by 7557.69% in 2024.
  • Angiodynamics' Goodwill & Intangibles (Quarter) stood at $366.7 million in 2021, then dropped by 6.55% to $342.7 million in 2022, then fell by 23.22% to $263.1 million in 2023, then tumbled by 72.21% to $73.1 million in 2024, then fell by 8.72% to $66.7 million in 2025.
  • Its Goodwill & Intangibles was $66.7 million in Q4 2025, compared to $68.4 million in Q3 2025 and $69.1 million in Q2 2025.